Plasminogen is the inactive, circulating precursor of plasmin, the final product of the fibrinolytic system. Therapy with plasminogen activators results in the generation of plasmin and intended thrombolysis.
Normal range: 70 " “113%.
Interpretation
Decreased In
Congenital: rare reported cases; may result in a predisposition to thrombosis
Acquired: severe DIC, pathologic fibrinolysis, or as the result of thrombolytic therapy, and in liver disease